<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________
SCHEDULE 13G
(Rule 13d-102)
INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. _____)/1/
CollaGenex Pharmaceuticals, Inc.
--------------------------------
(Name of Issuer)
Common Stock, $0.01 Par Value Per Share
---------------------------------------
(Title of Class of Securities)
19419B100
-----------------------
(CUSIP Number)
___________
_______________________
/1/ The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 15 Pages
<PAGE>
- ----------------------- ---------------------
CUSIP NO. 19419B100 13G PAGE 2 OF 15 PAGES
- ----------------------- ---------------------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON: Marquette Venture Partners II, L.P.
1
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: 36-3820302
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2 (a) [_]
(b) [_]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
Delaware
- ------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF
None
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
OWNED BY 890,860
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING
None
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
890,860
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
890,860
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
10
[_]
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
11
11.8%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12
PN
- ------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- ----------------------- ---------------------
CUSIP NO. 19419B100 13G PAGE 3 OF 15 PAGES
- ----------------------- ---------------------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON: MVP II AFFILIATES FUND, L.P.
1 S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: 36-3871877
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2 (a) [_]
(b) [_]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
DELAWARE
- ------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF NONE
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
25,453
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING NONE
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
25,453
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
25,453
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
10
[_]
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
11
0.3%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12
PN
- ------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- ------------------- ------------------
CUSIP NO. 19419B100 13G Page 4 of 15 Pages
- ------------------- ------------------
1 NAME OF REPORTING PERSON: Marquette General II, L.P.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: 36-3820303
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)[_]
(b)[_]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OR ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
None
SHARES -------------------------------------------------------
6 SHARED VOTING POWER
BENEFICIALLY
916,313
OWNED BY -------------------------------------------------------
7 SOLE DISPOSITIVE POWER
EACH
None
REPORTING -------------------------------------------------------
PERSON 8 SHARED DISPOSITIVE POWER
WITH 916,313
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
916,313
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
12.2%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- ----------------------- ---------------------
CUSIP NO. 19419B100 13G PAGE 5 OF 15 PAGES
- ----------------------- ---------------------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON: JED Limited Partnership
1
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: 36-3760173
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2 (a) [_]
(b) [_]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
Delaware
- ------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF
None
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
OWNED BY 916,313
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING
None
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
916,313
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
916,313
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
10
[_]
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
11
12.2%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12
PN
- ------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- ----------------------- ---------------------
CUSIP NO. 19419B100 13G PAGE 6 OF 15 PAGES
- ----------------------- ---------------------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON: LDR Limited Partnership
1
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: 36-3760176
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2 (a) [_]
(b) [_]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
Delaware
- ------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF
None
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
OWNED BY 916,313
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING
None
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
916,313
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
916,313
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
10
[_]
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
11
12.2%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12
PN
- ------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- ----------------------- ---------------------
CUSIP NO. 19419B100 13G PAGE 7 OF 15 PAGES
- ----------------------- ---------------------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON: James E. Daverman
1
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: ###-##-####
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2 (a) [_]
(b) [_]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
United States of America
- ------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF
None
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
OWNED BY 916,313
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING
None
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
916,313
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
916,313
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
10
[_]
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
11
12.2%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12
IN
- ------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- ----------------------- ---------------------
CUSIP NO. 19419B100 13G PAGE 8 OF 15 PAGES
- ----------------------- ---------------------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON: Lloyd D. Ruth
1
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: ###-##-####
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2 (a) [_]
(b) [_]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
United States of America
- ------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF
None
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
OWNED BY 916,313
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING
None
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
916,313
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
916,313
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
10
[_]
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
11
12.2%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12
IN
- ------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
Item 1(a) Name of Issuer:
--------------
CollaGenex Pharmaceuticals, Inc. ("CollaGenex")
Item 1(b) Address of Issuer's Principal Executive Offices:
-----------------------------------------------
301 S. State Street
Newtown, PA 18940
Item 2(a) Name of Person Filing:
---------------------
This Schedule 13G is being jointly filed by each of the following
persons pursuant to Rule 13d-1(f) promulgated by the Securities and
Exchange Commission pursuant to Section 13 of the Securities Exchange
Act of 1934, as amended (the "Act"): (i) Marquette Venture Partners
II, L.P. ("MVP II"), a Delaware limited partnership, by virtue of its
direct beneficial ownership of 890,860 shares of common stock, par
value $0.01 per share (the "Common Stock"), of CollaGenex; (ii) MVP
II Affiliates Fund, L.P. ("MVP II Affiliates"), a Delaware limited
partnership, by virtue of its direct beneficial ownership of 25,453
shares of Common Stock; (iii) Marquette General II, L.P. ("MG II"), a
Delaware limited partnership, as the sole general partner of MVP II
and MVP II Affiliates; (iv) JED Limited Partnership ("JED"), a
Delaware limited partnership, as a general partner of MG II; (v) LDR
Limited Partnership ("LDR"), a Delaware limited partnership, as a
general partner of MG II; (vi) James E. Daverman ("Mr. Daverman"), an
individual, as the sole general partner of JED; and (vii) Lloyd D.
Ruth ("Mr. Ruth"), an individual, as the sole general partner of LDR.
MVP II, MVP II Affiliates, MG II, JED, LDR, Mr. Daverman and Mr. Ruth
are hereinafter collectively referred to as the "Reporting Persons."
The Reporting Persons have entered into a Joint Filing Agreement,
dated February 13, 1997, a copy of which is filed with this Schedule
13G as Exhibit A, pursuant to which the Reporting Persons have agreed
to file this statement jointly in accordance with the provisions of
Rule 13d-1(f)(1) under the Act.
Item 2(b) Address of Principal Business Office or, if none,
Residence:
-----------------------------------------------
The address of the principal business office of each of the Reporting
Persons is:
Corporate 500 Centre
520 Lake Cook Road, Suite 450
Deerfield, Illinois 60015
Page 9 of 15 pages
<PAGE>
Item 2(c) Citizenship
-----------
MVP II, MVP II Affiliates, MG II, JED and LDR are limited
partnerships organized under the laws of Delaware.
Mr. Daverman and Mr. Ruth are United States citizens.
Item 2(d) Title of Class of Securities:
----------------------------
Common Stock, $0.01 par value per share.
Item 2(e) CUSIP No.:
---------
19419B100
Item 3 If this statement is filed pursuant to Rules 13d-1(b)
or 13d-2(b), check whether the persons filing is a:
----------------------------------------------------
The persons filing are not described in any category listed under
this item.
Item 4 Ownership
---------
MG II is the sole general partner of both MVP II and MVP II
Affiliates; JED and LDR are the general partners of MG II; Mr.
Daverman is the sole general partner of JED; and Mr. Ruth is the sole
general partners of LDR. As a result of such relationships, (i) MG
II, JED, LDR and both Messrs. Daverman and Ruth may be deemed to
share voting and dispositive power with respect to the shares held by
MVP II and MVP II Affiliates, and (ii) each of the Reporting Persons
may be deemed beneficially to own the following number of shares:
<TABLE>
<CAPTION>
(a) Amount Beneficially (b) Percent of Class:
Owned:
<S> <C> <C>
MVP II 890,860 11.8%
MVP II
Affiliates 25,453 0.3%
MG II 916,313 12.2%
JED 916,313 12.2%
LDR 916,313 12.2%
Daverman 916,313 12.2%
Ruth 916,313 12.2%
</TABLE>
Page 10 of 15 Pages
<PAGE>
(c) Number of shares as to which such person has:
(i) Sole power to vote or (ii) Shared power to vote or
direct the vote: to direct the vote:
<TABLE>
<CAPTION>
<S> <C> <C>
MVP II None 890,860
MVP II
Affiliates None 25,453
MG II None 916,313
JED None 916,313
LDR None 916,313
Daverman None 916,313
Ruth
None 916,313
(iii) Sole power to dispose or to (iv) Shared power to dispose or
direct the disposition of: to direct the disposition of:
MVP II None 890,860
MVP II
Affiliates None 25,453
MG II None 916,313
JED None 916,313
LDR None 916,313
Daverman None 916,313
Ruth None 916,313
</TABLE>
Each Reporting Person expressly disclaims beneficial ownership of any
shares of Common Stock beneficially owned by each other Reporting
Person.
Item 5 Ownership of Five Percent or Less of a Class:
--------------------------------------------
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check the
following [ ].
Item 6 Ownership of More Than Five Percent on Behalf of
Another Person:
------------------------------------------------
No other person has the right to receive or the power to direct the
receipt of dividends from, or other proceeds from the sale, of the
shares.
Page 11 of 15 Pages
<PAGE>
Item 7 Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the
Parent Holding Company:
--------------------------------------------------------
Not applicable.
Item 8 Identification and Classification of Members of the
Group:
------
Not applicable.
Item 9 Notice of Dissolution of Group:
------------------------------
Not applicable.
Item 10 Certification:
-------------
Not applicable.
Page 12 of 15 Pages
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: February 13, 1997
MARQUETTE VENTURE PARTNERS II, L.P.
MVP II AFFILIATES FUND, L.P.
MARQUETTE GENERAL II, L.P.
LDR LIMITED PARTNERSHIP
By: /s/ Lloyd D. Ruth
-------------------
Lloyd D. Ruth
as authorized signatory
JED LIMITED PARTNERSHIP
By: /s/ James E. Daverman
------------------------
James E. Daverman
as authorized signatory
/s/ James E. Daverman
------------------------
JAMES E. DAVERMAN
/s/ Lloyd D. Ruth
-------------------
LLOYD D. RUTH
Page 13 of 15 Pages
<PAGE>
Exhibit A
---------
AGREEMENT REGARDING THE JOINT FILING OF
SCHEDULE 13G
---------------------
The undersigned hereby agree as follows:
(i) Each of them is individually eligible to use the Schedule 13G
(the "Schedule 13G") to which this Exhibit is attached, and such Schedule 13G is
filed on behalf of each of them; and
(ii) Each of them is responsible for the timely filing of such
Schedule 13G and any subsequent amendments thereto, and for the completeness and
accuracy of the information concerning such person contained therein; but none
of them is responsible for the completeness or accuracy of the information
concerning the other persons making the filing, unless such person knows or has
reason to believe that such information is inaccurate.
Date: February 13, 1997
MARQUETTE VENTURE PARTNERS II, L.P.
MVP II AFFILIATES FUND, L.P.
MARQUETTE GENERAL II, L.P.
LDR LIMITED PARTNERSHIP
By: /s/ Lloyd D. Ruth
--------------------
Lloyd D. Ruth
as authorized signatory
JED LIMITED PARTNERSHIP
By: /s/ James E. Daverman
------------------------
James E. Daverman
as authorized signatory
Page 14 of 15 Pages
<PAGE>
/s/ James E. Daverman
------------------------
JAMES E. DAVERMAN
/s/ Lloyd D. Ruth
--------------------
LLOYD D. RUTH
Page 15 of 15 pages
